首页> 外文期刊>Journal of clinical pharmacy and therapeutics. >Combination therapy for disseminated strongyloidiasis with associated vancomycin‐resistant, linezolid‐intermediate Enterococcus faecium meningitis: A case report
【24h】

Combination therapy for disseminated strongyloidiasis with associated vancomycin‐resistant, linezolid‐intermediate Enterococcus faecium meningitis: A case report

机译:播散性类圆线虫病联合万古霉素耐药、利奈唑胺中间体屎肠球菌脑膜炎的联合治疗:病例报告

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract What is known and objective The rhabditid nematode Strongyloides stercoralis is the major causative agent of disseminated strongyloidiasis (DS). In rare cases, DS has caused enterococcal meningitis. If DS‐associated vancomycin‐resistant Enterococcus faecium (VRE) meningitis is suspected, combination antibiotic therapy should be considered. Case Summary We present a case of a 61‐year‐old male who developed DS associated with vancomycin‐resistant and linezolid‐intermediate E. faecium meningitis after receiving corticosteroids. The VRE meningitis was treated with high‐dose daptomycin 12?mg/kg, linezolid, tigecycline and quinupristin/dalfopristin. Despite negative cultures, the patient expired. What is new and conclusion In patients with DS‐associated VRE meningitis, early use of combination therapy may be warranted to improve patient outcomes.
机译:摘要 已知和客观的 横纹线虫 粪类圆线虫是播散性类圆线虫病(DS)的主要病原体。在极少数情况下,唐氏综合征会引起肠球菌性脑膜炎。如果怀疑 DS 相关的万古霉素耐药屎肠球菌 (VRE) 脑膜炎,应考虑联合抗生素治疗。病例摘要 我们介绍了一例 61 岁男性,他在接受皮质类固醇治疗后发生与万古霉素耐药和利奈唑胺中间体屎埃希菌脑膜炎相关的唐氏综合征。VRE脑膜炎采用大剂量达托霉素12?mg/kg、利奈唑胺、替加环素和奎努普汀/达福普汀治疗。尽管培养结果为阴性,但患者仍死亡。新进展和结论 在 DS 相关性 VRE 脑膜炎患者中,可能需要早期使用联合治疗以改善患者预后。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号